(Q22009131)

negative regulation of smooth muscle cell proliferation

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

E Hatzi

1

E

Hatzi

1 reference

PubMed

PubMed publication ID

10103013

7 February 2023

J Badet

series ordinal

2

author given names

J

author last names

Badet

1 reference

PubMed

PubMed publication ID

10103013

A putative angiogenin receptor in angiogenin-responsive human endothelial cells

7 February 2023

language of work or name

English

0 references

publication date

March 1999

0 references

published in

FEBS Journal

0 references

volume

260

0 references

issue

3

0 references

page(s)

825-32

0 references

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1432-1327.1999.00222.X

Amino acid sequence of human tumor derived angiogenin

20 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Characteristic ribonucleolytic activity of human angiogenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Base cleavage specificity of angiogenin with Saccharomyces cerevisiae and Escherichia coli 5S RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Characterization of ribonucleolytic activity of angiogenin towards tRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Dual site model for the organogenic activity of angiogenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Specific binding of angiogenin to calf pulmonary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Characterization of angiogenin receptors on bovine brain capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Isolation of angiogenin from normal human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Angiogenin activates phospholipase C and elicits a rapid incorporation of fatty acid into cholesterol esters in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Angiogenin depresses aortic smooth muscle cell cAMP by a pertussis toxin sensitive mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Chemical synthesis of a gene coding for human angiogenin, its expression in Escherichia coli and conversion of the product into its active form

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Expression of human angiogenin in cultured baby hamster kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Secretion of ribonucleases by normal and immortalized cells grown in serum-free culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Immortalization of primary human smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Actin is a binding protein for angiogenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Angiogenin antagonists prevent tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Density-dependent regulation of growth of BSC-1 cells in cell culture: control of growth by serum factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Proteoglycans as modulators of growth factor activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Protamine is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

7 January 2021

Smooth muscle cell and endothelial cell growth factors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

7 January 2021

Differentiated properties and proliferation of arterial smooth muscle cells in culture.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

7 January 2021

Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

7 January 2021

Interaction of heparin with human angiogenin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

7 January 2021

Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00222.X

7 January 2021